Successful treatment of field cancerization on the dorsum of the hands with 1% tirbanibulin ointment

Author:

Abril-Pérez Carlos12ORCID,Mansilla-Polo Miguel12ORCID,Martin-Torregrosa Daniel12,Botella-Estrada Rafael123

Affiliation:

1. Dermatology Department, Hospital Universitario y Politécnico La Fe , Valencia , Spain

2. Instituto de Investigación Sanitaria La Fe (IIS La Fe) , Valencia , Spain

3. Dermatology, Universitat de València , Valencia , Spain

Abstract

The management of actinic keratoses and field cancerization is a therapeutic challenge. Tirbanibulin 1% ointment is a promising new drug for use on specific parts of the body or in patients who are refractory or reluctant to use other more aggressive treatments.

Publisher

Oxford University Press (OUP)

Subject

Dermatology

Reference4 articles.

1. Actinic keratosis and cutaneous squamous cell carcinoma;Gutzmer;Dtsch Arztebl Int,2019

2. Efficacy of therapies for actinic keratosis;Lim;JAMA Dermatol,2022

3. Phase 3 trials of tirbanibulin ointment for actinic keratosis;Blauvelt;N Engl J Med,2021

4. Tirbanibulin: review of its novel mechanism of action and how it fits into the treatment of actinic keratosis;Gilaberte;Actas Dermosifiliogr,2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3